New Carbocyclic Amino Acid Derivatives Inhibit Infection Caused by Highly Pathogenic Influenza A Virus Strain (H5N1)

Bull Exp Biol Med. 2016 Jun;161(2):284-7. doi: 10.1007/s10517-016-3396-0. Epub 2016 Jul 7.

Abstract

New amino acid derivatives with carbocycles of adamantine and quinaldic acid were synthesized and their in vitro antiviral activity against influenza A/H5N1 virus was evaluated. Experiments on cultured embryonic porcine kidney epithelial cells showed that amino acid derivatives suppressed viral replication. Tret-butyloxycarbonyl-DL-methionylsulfonyl-1-adamantayl ethylamine and benzyloxycarbonyl-L-trypthophanyl-1-adamantayl ethylamine compounds demonstrated high activity in all in vitro experiments. Moreover, some compounds showed virucidal activity against influenza A/H5N1 virus.

Keywords: adamantane derivatives; amino acids; antiviral activity; influenza A/H5N1 virus; remantadine.

MeSH terms

  • Amino Acids / pharmacology*
  • Animals
  • Antiviral Agents / pharmacology*
  • Cells, Cultured
  • Drug Evaluation, Preclinical
  • Influenza A Virus, H5N1 Subtype / drug effects*
  • Influenza A Virus, H5N1 Subtype / physiology
  • Inhibitory Concentration 50
  • Rimantadine / pharmacology*
  • Sus scrofa
  • Virus Replication / drug effects*

Substances

  • Amino Acids
  • Antiviral Agents
  • Rimantadine